CVS Ordered To Pay $37 Million Fine For Stealing Medicaid Funds Through Elaborate Insulin Overbilling Plot

CVS has admitted responsibility and agreed to pay £28.3 million ($37.76 million) to settle a US healthcare fraud case over claims it billed government health programmes for excessive insulin refills between 2010 and 2020. (Credit: Ceeren/Wikimedia Commons)

CVS has agreed to pay £28.3 million ($37.76 million) and admitted responsibility after a decade of billing government health programmes for far more insulin than diabetic patients actually needed.

The national pharmacy chain settled a healthcare fraud lawsuit brought by the US Department of Justice, resolving claims that it repeatedly refilled insulin pen prescriptions too early and dispensed excess quantities between 2010 and 2020.